GRI Latest Press Releases

-- August 27, 2026 --

JTC Team Releases Virtual Investor "Why Now" On-Demand Conference Featuring Nine Public Company CEOs ACCESS Newswire 9:01 AM

GRI Bio Featured in "Why Now" On-Demand Video Webcast Globe Newswire 9:01 AM

-- August 24, 2026 --

GRI Bio to Present Late-Breaking Phase 2a GRI-0621 Data Highlighting Lung Function, Anti-Fibrotic Biomarkers and Favorable Tolerability in IPF at ERS 2026 Globe Newswire 9:05 AM

-- June 18, 2026 --

GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis Globe Newswire 8:31 AM

-- May 18, 2026 --

GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase Globe Newswire 9:15 AM

-- May 14, 2026 --

GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline Globe Newswire 8:35 AM

-- April 8, 2026 --

GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software